Immunology of Infectious Disease News 6.41 October 17, 2018 | |
| |
TOP STORYIn Utero Priming of Highly Functional Effector T Cell Responses to Human Malaria Researchers assessed the frequency, phenotype, and function of cord blood T cells from Ugandan infants born to mothers with and without placental malaria. They found that infants born to mothers with active placental malaria had elevated frequencies of proliferating effector memory fetal CD4+ T cells and higher frequencies of CD4+ and CD8+ T cells that produced inflammatory cytokines. [Sci Transl Med] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists developed a single-dose live-attenuated vaccine candidate that infected cells with controlled, limited infection rounds. The vaccine contained a 9-amino-acid deletion in the viral capsid protein and replicated to titers of > 106 focus-forming units/mL in cells expressing the full-length capsid protein. [Cell Host Microbe] Abstract | Graphical Abstract Investigators present the development and characterization of an inactivated recombinant Lassa virus (LASV) and rabies vaccine candidate that expressed a codon-optimized LASV glycoprotein and was adjuvanted by a TLR-4 agonist. [Nat Commun] Full Article | Editorial The authors showed that microRNA miR-27a was abundantly expressed in active tuberculosis patients, M. tuberculosis-infected mice and macrophages. The target of miR-27a was the ER-located Ca2+ transporter CACNA2D3. [Nat Commun] Full Article Researchers experimentally assessed the protection conferred by concurrent M. tuberculosis (Mtb) infection in macaques, a robust experimental model of human tuberculosis, using a combination of serial imaging and Mtb challenge strains differentiated by DNA identifiers. [PLoS Pathog] Full Article To evaluate the pulmonary CD4+ T-cell response during severe tuberculosis, C57BL/6 mice were infected with approximately 100 bacilli of 3 hypervirulent mycobacterial isolates or the H37Rv M. tuberculosis strain as reference for mycobacterial virulence. [J Infect Dis] Abstract To identify pathways commonly inhibited after malaria infection, investigators infected C57BL/6 mice with four P. yoelii strains causing different disease phenotypes and 24 progeny of a genetic cross. [Sci Rep] Full Article The authors performed extensive B and T-lymphocyte phenotyping in patients with acute infectious spondylodiscitis at diagnosis and after treatment cessation. In this prospective multicentre study, flow cytometric analysis of T and B-lymphocyte subsets was performed in 35 patients at diagnosis and three months after treatment cessation. [Sci Rep] Full Article Investigators examined the immunogenicity of priming with intramuscular pNGVL4a-Sig/E7(detox)/HSP70 followed by TA-HPV boost through different administration routes. They observed that priming twice with a pNGVL4a-Sig/E7(detox)/HSP70 followed by a single TA-HPV immunization boost through skin scarification generated the strongest antigen-specific CD8+ T cell response in C57BL/6 mice. [Virology] Abstract Subscribe to our sister publications: Human Immunology News & Immune Regulation News. | |
| |
REVIEWSMalaria Prevention: From Immunological Concepts to Effective Vaccines and Protective Antibodies The authors focus on the current understanding of immunological mechanisms of protection from animal models and human vaccine studies, and on how these data should inform the development of next-generation vaccines. Furthermore, they introduce the concept of using passive immunization with monoclonal antibodies as a new approach to prevent and eliminate malaria. [Nat Immunol] Abstract The Immune Response against Flaviviruses Scientists examine the dual role of the adaptive immune response against flaviviruses, particularly emphasizing the most recent findings regarding cross-reactive T cell and antibody responses, and the effects that these concepts have on vaccine-development endeavors. [Nat Immunol] Abstract Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field. | |
| |
INDUSTRY NEWSFluGen, Inc. announced that all subjects have completed dosing in a first-of-its-kind clinical study which challenged subjects with an influenza virus that was intentionally mismatched by six years from the influenza strain utilized in FluGen’s M2SR vaccine. [FluGen, Inc. (Business Wire, Inc.)] Press Release Eiger BioPharmaceuticals, Inc. announced positive data with pegylated interferon lambda in the Phase II LIMT HDV study. [Eiger BioPharmaceuticals, Inc.] Press Release | |
| |
POLICY NEWSBeset by economic woes and dissatisfied with the left-wing politicians in power for most of the past 15 years, Brazil appears poised to make a hard turn and elect a far-right candidate, Jair Bolsonaro, as its next president. His rapid ascent has unnerved local researchers, who worry about the future of Brazilian science, the protection of the country’s biodiversity, and its role in the global struggle against climate change. [ScienceInsider] Editorial Outsider Takes Helm at Indian Research Giant Shekhar Mande, a structural biologist, took over as director-general of India’s Council of Scientific and Industrial Research (CSIR), headquartered in New Delhi, which operates a network of 40 research labs around the country. Mande is the first outsider to take on the top job at CSIR since 1984. [ScienceInsider] Editorial China Awaits Controversial Blacklist of ‘Poor Quality’ Journals A proposal by the Chinese government to create a national blacklist of journals is creating much debate among the country’s scientists, who are still waiting for the list to be revealed, five months after the plan to create it was announced. [Nature News] Editorial
| |
EVENTSNEW Defence is the Best Attack: Immuno-Oncology Breakthroughs Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Vaccines and Immunity (Nationwide Children’s Hospital) Postdoctoral Position – Innate Immunity, Virology (Technical University of Munich) Research Fellow – Cellular Immunology (A*STAR) Research Fellow – Immunology (Dana-Farber Cancer Institute) Assistant Professor – Immunology (Ragon Institute of MGH, MIT and Harvard) Associate/Full Specialist – Host-Pathogen Interactions (University of California, San Francisco) Graduate Training Program – RNA & Infection (Helmholtz Centre for Infection Research) Postdoctoral Scholar – Hepatitis B Infection (The Pennsylvania State University College of Medicine) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|